• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

虫草素预处理对小鼠肝缺血/再灌注损伤的保护作用。

Protective effects of cordycepin pretreatment against liver ischemia/reperfusion injury in mice.

机构信息

Department of Anesthesiology, Tianjin First Central Hospital, Tianjin, China.

出版信息

Immun Inflamm Dis. 2023 Mar;11(3):e792. doi: 10.1002/iid3.792.

DOI:10.1002/iid3.792
PMID:36988254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10013135/
Abstract

INTRODUCTION

Cordycepin has been reported to exhibit hepatic protective and anti-inflammatory properties. Here, we investigated the role of cordycepin in ischemia/reperfusion (IR)-induced liver injury in a mouse model.

METHODS

Mice were pretreated with cordycepin by gavage for 3 weeks, followed by the establishment of the IR modeling. Liver injury, Suzuki's histological grading, hepatic apoptosis, and inflammatory responses were evaluated by biochemical and pathological analysis.

RESULTS

It was found that Cordycepin pretreatment at 50 mg/kg for 3 weeks attenuated IR-induced liver injury, as reflected by the significant decrease of the levels of aspartate aminotransferase, alanine transaminase, lactate dehydrogenase, and low-density lipoprotein. Cordycepin pretreatment also reduced histopathological changes, attenuated hepatocyte apoptosis, inflammatory responses in the livers of IR mice. Mechanically, toll-like receptor 4/nuclear factor kappa-B signaling in liver tissues was inhibited by Cordycepin pretreatment.

CONCLUSIONS

In conclusion, Cordycepin pretreatment protects IR-induced liver injury, which demonstrates its potential for the treatment of IR in the liver.

摘要

简介

蛹虫草素有肝保护和抗炎作用。在这里,我们研究了蛹虫草素在小鼠模型中缺血/再灌注(IR)诱导的肝损伤中的作用。

方法

通过灌胃预处理小鼠蛹虫草素 3 周,然后建立 IR 模型。通过生化和病理分析评估肝损伤、 Suzuki 组织学分级、肝凋亡和炎症反应。

结果

发现蛹虫草素预处理 50mg/kg 3 周可减轻 IR 引起的肝损伤,表现为天冬氨酸转氨酶、丙氨酸转氨酶、乳酸脱氢酶和低密度脂蛋白水平显著降低。蛹虫草素预处理还减轻了 IR 小鼠肝脏的组织病理学变化,减轻了肝实质细胞凋亡和炎症反应。机制上,蛹虫草素预处理抑制了肝组织中 Toll 样受体 4/核因子 kappa-B 信号通路。

结论

综上所述,蛹虫草素预处理可保护 IR 诱导的肝损伤,表明其在治疗肝脏 IR 方面具有潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/cf543c599cf8/IID3-11-e792-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/3a76c9a2dd6a/IID3-11-e792-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/6fd2b5603c27/IID3-11-e792-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/a48f5860440a/IID3-11-e792-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/8428c22fd66f/IID3-11-e792-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/cf543c599cf8/IID3-11-e792-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/3a76c9a2dd6a/IID3-11-e792-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/6fd2b5603c27/IID3-11-e792-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/a48f5860440a/IID3-11-e792-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/8428c22fd66f/IID3-11-e792-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/10013135/cf543c599cf8/IID3-11-e792-g005.jpg

相似文献

1
Protective effects of cordycepin pretreatment against liver ischemia/reperfusion injury in mice.虫草素预处理对小鼠肝缺血/再灌注损伤的保护作用。
Immun Inflamm Dis. 2023 Mar;11(3):e792. doi: 10.1002/iid3.792.
2
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-B Pathway.蛹虫草素通过抑制 MAPK/NF-B 通路保护肝脏缺血/再灌注损伤。
Mediators Inflamm. 2022 Jul 22;2022:5676256. doi: 10.1155/2022/5676256. eCollection 2022.
3
Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo.白藜芦醇预处理通过Toll样受体4/核因子-κB信号通路在体外和体内保护肝细胞免受肝缺血再灌注损伤。
Int Immunopharmacol. 2016 Jun;35:201-209. doi: 10.1016/j.intimp.2016.03.032. Epub 2016 Apr 16.
4
Alpinetin protects against hepatic ischemia/reperfusion injury in mice by inhibiting the NF-κB/MAPK signaling pathways.白杨素通过抑制 NF-κB/MAPK 信号通路保护小鼠肝缺血/再灌注损伤。
Int Immunopharmacol. 2021 Jun;95:107527. doi: 10.1016/j.intimp.2021.107527. Epub 2021 Mar 18.
5
Gastrodin Pretreatment Protects Liver Against Ischemia-Reperfusion Injury via Activation of the Nrf2/HO-1 Pathway.天麻预处理通过激活 Nrf2/HO-1 通路保护肝脏免受缺血再灌注损伤。
Am J Chin Med. 2020;48(5):1159-1178. doi: 10.1142/S0192415X20500573.
6
Ginsenoside Rg1 protects mouse liver against ischemia-reperfusion injury through anti-inflammatory and anti-apoptosis properties.人参皂苷Rg1通过抗炎和抗凋亡特性保护小鼠肝脏免受缺血再灌注损伤。
J Surg Res. 2014 Sep;191(1):231-8. doi: 10.1016/j.jss.2014.03.067. Epub 2014 Mar 26.
7
ATF3-mediated NRF2/HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia/reperfusion injury.ATF3介导的NRF2/HO-1信号通路调节小鼠肝脏缺血/再灌注损伤中的TLR4天然免疫反应。
Am J Transplant. 2015 Jan;15(1):76-87. doi: 10.1111/ajt.12954. Epub 2014 Oct 30.
8
Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-B Signaling Pathway.维达列汀通过 TLR4/NF-B 信号通路减轻肝缺血/再灌注损伤。
Oxid Med Cell Longev. 2018 Oct 14;2018:3509091. doi: 10.1155/2018/3509091. eCollection 2018.
9
Ergothioneine pretreatment protects the liver from ischemia-reperfusion injury caused by increasing hepatic heat shock protein 70.麦角硫因预处理通过增加肝脏热休克蛋白70来保护肝脏免受缺血-再灌注损伤。
J Surg Res. 2004 Nov;122(1):96-102. doi: 10.1016/j.jss.2004.06.016.
10
Protective Effects of Cinnamaldehyde against Mesenteric Ischemia-Reperfusion-Induced Lung and Liver Injuries in Rats.肉桂醛对大鼠肠缺血再灌注诱导的肺和肝损伤的保护作用。
Oxid Med Cell Longev. 2020 Dec 9;2020:4196548. doi: 10.1155/2020/4196548. eCollection 2020.

引用本文的文献

1
Nepetoidin B Alleviates Liver Ischemia/Reperfusion Injury via Regulating MKP5 and JNK/P38 Pathway.去甲蟛蜞菊内酯 B 通过调控 MKP5 和 JNK/P38 通路减轻肝缺血/再灌注损伤。
Drug Des Devel Ther. 2024 Jun 17;18:2301-2315. doi: 10.2147/DDDT.S457130. eCollection 2024.

本文引用的文献

1
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-B Pathway.蛹虫草素通过抑制 MAPK/NF-B 通路保护肝脏缺血/再灌注损伤。
Mediators Inflamm. 2022 Jul 22;2022:5676256. doi: 10.1155/2022/5676256. eCollection 2022.
2
Cordycepin induces M1/M2 macrophage polarization to attenuate the liver and lung damage and immunodeficiency in immature mice with sepsis via NF-κB/p65 inhibition.虫草素通过抑制NF-κB/p65诱导M1/M2巨噬细胞极化,减轻脓毒症未成熟小鼠的肝肺损伤和免疫缺陷。
J Pharm Pharmacol. 2022 Feb 1;74(2):227-235. doi: 10.1093/jpp/rgab162.
3
Cordycepin attenuates high-fat diet-induced non-alcoholic fatty liver disease via down-regulation of lipid metabolism and inflammatory responses.
虫草素通过下调脂质代谢和炎症反应来减轻高脂饮食诱导的非酒精性脂肪肝疾病。
Int Immunopharmacol. 2021 Feb;91:107173. doi: 10.1016/j.intimp.2020.107173. Epub 2020 Dec 23.
4
Hepatic Macrophages in Liver Injury.肝脏损伤中的肝巨噬细胞。
Front Immunol. 2020 Apr 17;11:322. doi: 10.3389/fimmu.2020.00322. eCollection 2020.
5
Alternatively activated macrophages promote resolution of necrosis following acute liver injury. alternatively 激活的巨噬细胞促进急性肝损伤后坏死的消退。
J Hepatol. 2020 Aug;73(2):349-360. doi: 10.1016/j.jhep.2020.02.031. Epub 2020 Mar 11.
6
A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepin.一种新型核苷挽救代谢途径可能是口服蛹虫草苷治疗效果的原因。
Sci Rep. 2019 Oct 31;9(1):15760. doi: 10.1038/s41598-019-52254-x.
7
Glycyrrhetinic acid pretreatment attenuates liver ischemia/reperfusion injury via inhibiting TLR4 signaling cascade in mice.甘草次酸预处理通过抑制 TLR4 信号级联减轻小鼠肝缺血/再灌注损伤。
Int Immunopharmacol. 2019 Nov;76:105870. doi: 10.1016/j.intimp.2019.105870. Epub 2019 Sep 4.
8
Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of .虫草素(一种生物活性化合物)的抗肿瘤和抗转移作用
Saudi J Biol Sci. 2018 Jul;25(5):991-995. doi: 10.1016/j.sjbs.2018.05.016. Epub 2018 May 14.
9
Isoquercetin ameliorates myocardial infarction through anti-inflammation and anti-apoptosis factor and regulating TLR4-NF-κB signal pathway.异槲皮苷通过抗炎和抗凋亡因子及调控 TLR4-NF-κB 信号通路改善心肌梗死。
Mol Med Rep. 2018 May;17(5):6675-6680. doi: 10.3892/mmr.2018.8709. Epub 2018 Mar 9.
10
Development of Cordycepin Formulations for Preclinical and Clinical Studies.蛹虫草素制剂的临床前和临床研究进展。
AAPS PharmSciTech. 2017 Nov;18(8):3219-3226. doi: 10.1208/s12249-017-0795-0. Epub 2017 May 30.